Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-11) in combination with quercetin: possible contribution of P-glycoprotein.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Life Science

• Publication date

  2008-08-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.lfs.2008.06.007PMID 18619980
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multiplicity of biliary excretion mechanisms for the camptothecin derivative irinotecan (CPT-11), its metabolite SN-38, and its glucuronide: role of canalicular multispecific organic anion transporter and P-glycoprotein

  2009cited by this paper
• Development and validation of reversed phase liquid chromatographic method utilizing ultraviolet detection for quantification of irinotecan (CPT-11) and its active metabolite, SN-38, in rat plasma and bile samples: application to pharmacokinetic studies.

  2008cited by this paper
• Concurrent determination of topotecan and model permeability markers (atenolol, antipyrine, propranolol and furosemide) by reversed phase liquid chromatography: utility in Caco-2 intestinal absorption studies.

  2007cited by this paper
• Concise review: Clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein).

  2007cited by this paper
• Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats.

  2006cited by this paper
• Flavonoid-drug interactions: effects of flavonoids on ABC transporters.

  2006cited by this paper
• Bidirectional membrane transport: simulations of transport inhibition in uptake studies explain data obtained with flavonoids.

  2006cited by this paper
• Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients.

  2006cited by this paper
• Altered oral bioavailability and pharmacokinetics of P-glycoprotein substrates by coadministration of biochanin A.

  2006cited by this paper
• St. John’s Wort Modulates the Toxicities and Pharmacokinetics of CPT-11 (Irinotecan) in Rats

  2005cited by this paper
• Loperamide inhibits the biliary excretion of irinotecan (CPT‐11) in the rat isolated perfused liver

  2005cited by this paper
• Characterization of secretory intestinal transport of the lactone form of CPT-11

  2005cited by this paper
• FLAVONOIDS CHRYSIN AND BENZOFLAVONE, POTENT BREAST CANCER RESISTANCE PROTEIN INHIBITORS, HAVE NO SIGNIFICANT EFFECT ON TOPOTECAN PHARMACOKINETICS IN RATS OR MDR1A/1B (–/–) MICE

  2005cited by this paper
• Uptake of irinotecan metabolite SN-38 by the human intestinal cell line Caco-2

  2005cited by this paper
• Novel agents that potentially inhibit irinotecan-induced diarrhea.

  2005cited by this paper
• Enhanced diltiazem bioavailability after oral administration of diltiazem with quercetin to rabbits.

  2005cited by this paper
• Modulation of drug transport by selected flavonoids: Involvement of P-gp and OCT?

  2005cited by this paper
• Enhanced paclitaxel bioavailability after oral coadministration of paclitaxel prodrug with naringin to rats.

  2005cited by this paper
• Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats.

  2005influential reference
• Herbal Modulation of P‐Glycoprotein

  2004cited by this paper
• Lethal quercetin-digoxin interaction in pigs.

  2004cited by this paper
• Flavonoid permeability across an in situ model of the blood-brain barrier.

  2004cited by this paper
• Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport.

  2004cited by this paper
• Gefitinib Enhances the Antitumor Activity and Oral Bioavailability of Irinotecan in Mice

  2004cited by this paper
• Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin.

  2004influential reference
• Effects of Extracts of Commonly Consumed Food Supplements and Food Fractions on the Permeability of Drugs Across Caco-2 Cell Monolayers

  2004cited by this paper
• Enhanced bioavailability of paclitaxel after oral coadministration with flavone in rats.

  2004influential reference
• Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin.

  2003cited by this paper
• Effect of P-Glycoprotein Modulator, Cyclosporin A, on the Gastrointestinal Excretion of Irinotecan and Its Metabolite SN-38 in Rats

  2003cited by this paper
• Rhodamine 123 Requires Carrier-Mediated Influx for Its Activity as a P-Glycoprotein Substrate in Caco-2 Cells

  2003cited by this paper
• Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918.

  2002cited by this paper
• The potential for an interaction between MRP2 (ABCC2) and various therapeutic agents: probenecid as a candidate inhibitor of the biliary excretion of irinotecan metabolites.

  2002cited by this paper
• Piperine, a Major Constituent of Black Pepper, Inhibits Human P-glycoprotein and CYP3A4

  2002cited by this paper
• Intestinal transport of irinotecan in Caco-2 cells and MDCK II cells overexpressing efflux transporters Pgp, cMOAT, and MRP1.

  2002cited by this paper
• Quercetin significantly decreased cyclosporin oral bioavailability in pigs and rats.

  2002influential reference
• Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells.

  2002cited by this paper
• Biliary transport of irinotecan and metabolites in normal and P-glycoprotein-deficient mice

  2002cited by this paper
• Active transepithelial transport of irinotecan (CPT-11) and its metabolites by human intestinal Caco-2 cells

  2001cited by this paper
• Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).

  2001cited by this paper
• Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan.

  2000cited by this paper
• Coadministration of oral cyclosporin A enables oral therapy with paclitaxel.

  1999cited by this paper
• MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening.

  1999influential reference
• Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein.

  1998cited by this paper
• Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833.

  1997cited by this paper
• Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats.

  1997cited by this paper
• Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein.

  1997cited by this paper
• Pharmacokinetic modulation of irinotecan and metabolites by cyclosporin A.

  1996cited by this paper
• Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979.

  1996cited by this paper
• Irinotecan (CPT-11) metabolites in human bile and urine.

  1996cited by this paper
• Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism.

  1994cited by this paper
• In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative.

  1993cited by this paper
• Interaction of citrus juices with felodipine and nifedipine.

  1991cited by this paper

• Advances and Perspectives on the Anti-Fibrotic Mechanisms of the Quercetin.

  2025cites this paper
• Safety evaluation of irinotecan: a real-world disproportionality analysis using FAERS and JADER databases during the time period 2004-2024

  2025cites this paper
• A comprehensive review on pharmacokinetic mechanism of herb-herb/drug interactions in Chinese herbal formula.

  2024cites this paper
• Potential Strategies for Overcoming Drug Resistance Pathways Using Propolis and Its Polyphenolic/Flavonoid Compounds in Combination with Chemotherapy and Radiotherapy

  2024cites this paper
• Therapeutic Potential of Quercetin as an Antioxidant for Bone-Muscle-Tendon Regeneration and Aging

  2024cites this paper
• Folic acid-chitosan functionalized polymeric nanocarriers to treat colon cancer.

  2023cites this paper
• Herbal Medicines as adjuvants for the treatment of chemotherapy-induced diarrhea.

  2023cites this paper
• CD44 mediated colon cancer targeting mutlifaceted lignin nanoparticles: Synthesis, in vitro characterization and in vivo efficacy studies.

  2023cites this paper
• Orally delivered solid lipid nanoparticles of irinotecan coupled with chitosan surface modification to treat colon cancer: Preparation, in-vitro and in-vivo evaluations.

  2022cites this paper
• Bioenhancing effects of piperine and curcumin on triterpenoid pharmacokinetics and neurodegenerative metabolomes from Centella asiatica extract in beagle dogs

  2022cites this paper
• Advances in Pharmacokinetic Mechanisms of Transporter-Mediated Herb-Drug Interactions

  2022cites this paper
• A Brief Overview of Potential Treatments for Viral Diseases Using Natural Plant Compounds: The Case of SARS-Cov

  2021cites this paper
• Hesperetin’s health potential: moving from preclinical to clinical evidence and bioavailability issues, to upcoming strategies to overcome current limitations

  2021cites this paper
• Title: New Approaches with Natural Product Drugs for Overcoming Multidrug Resistance in Cancer Short running title: Natural Products and Cancer MDR

  2020cites this paper
• Influence of the Phenological State of in the Antioxidant Potential and Chemical Composition of Ageratina havanensis. Effects on the P-Glycoprotein Function

  2020cites this paper
• Bioavailability enhancement of poorly soluble drugs: The holy grail in pharma industry.

  2019cites this paper
• Drug Bioavailability Enhancing Agents of Natural Origin (Bioenhancers) that Modulate Drug Membrane Permeation and Pre-Systemic Metabolism

  2019cites this paper
• Effect of irinotecan on the tongue mucosa of juvenile male albino rat at adulthood

  2019cites this paper
• Characterization of a liposomal copper(II)-quercetin formulation suitable for parenteral use

  2019cites this paper
• Evaluation of the Mrp2-mediated flavonoid-drug interaction potential of quercetin in rats and in vitro models

  2019cites this paper
• Novel 4-in-1 strategy to combat colon cancer, drug resistance and cancer relapse utilizing functionalized bioinspiring lignin nanoparticle.

  2018cites this paper
• RETRACTED ARTICLE: Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations

  2018cites this paper
• Irinotecan and Δ9-Tetrahydrocannabinol Interactions in Rat Liver: A Preliminary Evaluation Using Biochemical and Genotoxicity Markers

  2018cites this paper
• Flavonoid compounds as reversing agents of the P-glycoprotein-mediated multidrug resistance: An in vitro evaluation with focus on antiepileptic drugs.

  2018cites this paper
• In vitro screening of dual flavonoid combinations for reversing P-glycoprotein-mediated multidrug resistance: Focus on antiepileptic drugs.

  2018cites this paper
• Safety Aspects of the Use of Quercetin as a Dietary Supplement

  2018cites this paper
• Coadministration of antiepileptic drugs and P-glycoprotein inhibitors of flavonoid-type

  2018cites this paper
• Microscale Mass Spectrometry Analysis of Extracellular Metabolites in Live Multicellular Tumor Spheroids.

  2017cites this paper
• P-gp Inhibition-Based Strategies for Modulating Pharmacokinetics of Anticancer Drugs: An Update.

  2016cites this paper
• Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: an in vitro, ex vivo and in vivo investigations

  2016cites this paper
• Transporter modulation by Chinese herbal medicines and its mediated pharmacokinetic herb-drug interactions.

  2016cites this paper
• [Herb-drug enzyme-mediated interactions and the associated experimental methods: a review].

  2016cites this paper
• Herb-drug enzyme-mediated interactions and the associated experimental methods: a review

  2016cites this paper
• Square wave cathodic adsorptive stripping voltammetric determination of the anticancer drugs flutamide and irinotecan in biological fluids using renewable pencil graphite electrodes

  2016cites this paper
• Molecular mechanisms of action of quercetin in cancer: recent advances

  2016cites this paper
• Pharmacokinetic herb–drug interactions with traditional Chinese medicine: progress, causes of conflicting results and suggestions for future research

  2016cites this paper
• Solid lipid nanoparticles containing 7-ethyl-10-hydroxycamptothecin (SN38): Preparation, characterization, in vitro, and in vivo evaluations.

  2016cites this paper
• Quercetin Inhibits Proliferation and Drug Resistance in KB/VCR Oral Cancer Cells and Enhances Its Sensitivity to Vincristine

  2015cites this paper
• Flavonoid compounds as reversal agents of the P-glycoprotein-mediated multidrug resistance: biology, chemistry and pharmacology

  2015influential citation
• New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer.

  2015cites this paper
• Interaction of Drug or Food with Drug Transporters in Intestine and Liver.

  2015cites this paper
• Advances in P-glycoprotein-based approaches for delivering anticancer drugs: pharmacokinetic perspective and clinical relevance

  2014cites this paper
• Combination Effects of Quercetin, Resveratrol and Curcumin on In Vitro Intestinal Absorption

  2014cites this paper
• Pharmacokinetic evaluation of C-3 modified 1,8-naphthyridine-3-carboxamide derivatives with potent anticancer activity: lead finding

  2014cites this paper
• Understanding the Transport Properties of Metabolites: Case Studies and Considerations for Drug Development

  2014cites this paper
• Effect of single-dose and short-term administration of quercetin on the pharmacokinetics of talinolol in humans - Implications for the evaluation of transporter-mediated flavonoid-drug interactions.

  2014cites this paper
• Physiological modulation approaches to improve cancer chemotherapy : a review.

  2014cites this paper
• Role of herbal bioactives as a potential bioavailability enhancer for Active Pharmaceutical Ingredients.

  2014cites this paper
• Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.

  2013cites this paper
• Nano scale self-emulsifying oil based carrier system for improved oral bioavailability of camptothecin derivative by P-Glycoprotein modulation.

  2013cites this paper
• Comparative pharmacokinetics of paclitaxel after oral administration of Taxus yunnanensis extract and pure paclitaxel to rats.

  2013cites this paper
• Enhanced Permeability of Etoposide across Everted Sacs of Rat Small Intestine by Vitamin E-TPGS

  2013cites this paper
• Oral Anticancer Drugs: Mechanisms of Low Bioavailability and Strategies for Improvement

  2013cites this paper
• The effects of flavonoids on the ABC transporters: consequences for the pharmacokinetics of substrate drugs

  2013cites this paper
• Inhibition of ATP-Binding Cassette Transporters by Chinese Herbs and Phytochemicals

  2013cites this paper
• Synthesis and preliminary anticancer evaluation of 10-hydroxycamptothecin analogs.

  2012cites this paper
• Combination therapy of Western drugs and herbal medicines: recent advances in understanding interactions involving metabolism and efflux

  2012cites this paper
• P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs.

  2012cites this paper
• Curcumin bioavailability from enriched bread: the effect of microencapsulated ingredients.

  2012cites this paper
• Effect of Herbal Supplement–Drug Interactions on Therapeutic Drug Monitoring

  2012cites this paper
• Use of primary rat hepatocytes in the gel entrapment culture to predict in vivo biliary excretion

  2012cites this paper
• In Situ intestinal perfusion of irinotecan: application to P-gp mediated drug interaction and introduction of an improved HPLC assay.

  2011cites this paper
• Assessment of Anti-Cytogenotoxic Effects of Quercetin in Animals Treated with Topotecan

  2011influential citation
• Irinotecan and its active metabolite, SN-38: review of bioanalytical methods and recent update from clinical pharmacology perspectives.

  2010cites this paper
• Quercetin as a Potential Modulator of P-Glycoprotein Expression and Function in Cells of Human Pancreatic Carcinoma Line Resistant to Daunorubicin

  2010cites this paper
• Quercetin: a potential drug to reverse multidrug resistance.

  2010cites this paper
• Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy.

  2009cites this paper
• Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats.

  2009cites this paper
• Clinical Significance of UDP-Glucuronosyltransferase 1A1*6 for Toxicities of Combination Chemotherapy with Irinotecan and Cisplatin in Gynecologic Cancers

  2009cites this paper